Euan Posted August 5, 2013 Share Posted August 5, 2013 I see that abiraterone has been added to the PBS and here are the prescribing restrictions: Castration resistant metastatic carcinoma of the prostate The Clinical criteria is: The treatment must be in combination with prednisone or prednisolone, AND the Clinical criteria is: The treatment must not be used in combination with chemotherapy, AND the Clinical criteria is: Patient must have failed treatment with docetaxel due to resistance or intolerance, AND the Clinical criteria is: Patient must have a WHO performance status of 2 or less, AND the Clinical criteria is: Patient must not receive PBS-subsidised abiraterone if progressive disease develops while on abiraterone. The WHO performance status simple means that the person is not confined to bed for at least 50% of waking hours. The dispensed price is $3600.11 for 120 tablets. Dose is 4 tablets daily together on an empty stomach. Cheers, Euan Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.